United Therapeutics Revenue 2006-2020 | UTHR

United Therapeutics revenue from 2006 to 2020. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
United Therapeutics Annual Revenue
(Millions of US $)
2019 $1,449
2018 $1,628
2017 $1,725
2016 $1,599
2015 $1,466
2014 $1,289
2013 $1,117
2012 $916
2011 $743
2010 $593
2009 $359
2008 $281
2007 $211
2006 $160
2005 $116
United Therapeutics Quarterly Revenue
(Millions of US $)
2020-06-30 $362
2020-03-31 $356
2019-12-31 $311
2019-09-30 $402
2019-06-30 $374
2019-03-31 $363
2018-12-31 $381
2018-09-30 $413
2018-06-30 $445
2018-03-31 $389
2017-12-31 $465
2017-09-30 $446
2017-06-30 $445
2017-03-31 $371
2016-12-31 $409
2016-09-30 $408
2016-06-30 $413
2016-03-31 $369
2015-12-31 $405
2015-09-30 $386
2015-06-30 $347
2015-03-31 $328
2014-12-31 $346
2014-09-30 $330
2014-06-30 $323
2014-03-31 $289
2013-12-31 $289
2013-09-30 $302
2013-06-30 $281
2013-03-31 $245
2012-12-31 $244
2012-09-30 $242
2012-06-30 $226
2012-03-31 $204
2011-12-31 $195
2011-09-30 $202
2011-06-30 $184
2011-03-31 $163
2010-12-31 $161
2010-09-30 $169
2010-06-30 $135
2010-03-31 $129
2009-12-31 $98
2009-09-30 $97
2009-06-30 $84
2009-03-31 $80
2008-12-31 $76
2008-09-30 $75
2008-06-30 $69
2008-03-31 $62
2007-12-31 $60
2007-09-30 $59
2007-06-30 $52
2007-03-31 $40
2006-12-31 $46
2006-09-30 $40
2006-06-30 $40
2006-03-31 $33
2005-12-31 $30
2005-09-30 $33
2005-06-30 $30
2005-03-31 $23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.848B $1.449B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.564B 42.41
Takeda Pharmaceutical (TAK) Japan $58.294B 10.16
Astellas Pharma (ALPMY) Japan $29.965B 15.18
Eisai (ESALY) Japan $27.403B 23.16
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.131B 22.47
Catalent (CTLT) United States $13.151B 50.84
Grifols, S.A (GRFS) Spain $12.369B 15.12
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.539B 40.80
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.463B 47.27
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.803B 11.25
Arrowhead Pharmaceuticals (ARWR) United States $4.151B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $4.069B 0.00
Hypermarcas (HYPMY) Brazil $3.887B 14.30
ChemoCentryx (CCXI) United States $3.697B 0.00
Nektar Therapeutics (NKTR) United States $3.650B 0.00
PTC Therapeutics (PTCT) United States $3.250B 0.00
Sage Therapeutics (SAGE) United States $2.670B 0.00
Pacira BioSciences (PCRX) United States $2.563B 67.37
Taro Pharmaceutical Industries (TARO) Israel $2.442B 11.82
Cronos Group (CRON) Canada $1.942B 0.00
Revolution Medicines (RVMD) United States $1.848B 0.00
Xencor (XNCR) United States $1.832B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.765B 0.00
USANA Health Sciences (USNA) United States $1.741B 16.40
Indivior (INVVY) United States $1.614B 20.00
Ironwood Pharmaceuticals (IRWD) United States $1.583B 11.03
Corcept Therapeutics (CORT) United States $1.561B 14.37
Akebia Therapeutics (AKBA) United States $1.473B 0.00
Heron Therapeutics (HRTX) United States $1.413B 0.00
Zogenix (ZGNX) United States $1.372B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.264B 12.06
VAXART, INC (VXRT) United States $1.174B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.090B 0.00
Karyopharm Therapeutics (KPTI) United States $1.078B 0.00
Translate Bio (TBIO) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.951B 592.13
Esperion Therapeutics (ESPR) United States $0.932B 0.00
Tilray (TLRY) Canada $0.865B 0.00
Altimmune (ALT) United States $0.739B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.729B 1.08
Trillium Therapeutics (TRIL) Canada $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.699B 0.00
ImmunoGen (IMGN) United States $0.672B 0.00
Collegium Pharmaceutical (COLL) United States $0.653B 0.00
Molecular Templates (MTEM) United States $0.599B 0.00
Flexion Therapeutics (FLXN) United States $0.597B 0.00
Radius Health (RDUS) United States $0.574B 0.00
Aerie Pharmaceuticals (AERI) United States $0.572B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.569B 0.00
Siga Technologies (SIGA) United States $0.554B 59.08
Crinetics Pharmaceuticals (CRNX) United States $0.516B 0.00
Ocular Therapeutix (OCUL) United States $0.510B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Ardelyx (ARDX) United States $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.36
DURECT (DRRX) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.429B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.346B 8.56
Harpoon Therapeutics (HARP) United States $0.344B 0.00
IMV INC (IMV) Canada $0.335B 0.00
Redhill Biopharma (RDHL) Israel $0.316B 0.00
Heat Biologics (HTBX) United States $0.316B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Calithera Biosciences (CALA) United States $0.293B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.290B 0.00
Rafael Holdings (RFL) United States $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.279B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.275B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.240B 0.00
Aquestive Therapeutics (AQST) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.216B 21.33
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Onconova Therapeutics (ONTX) United States $0.186B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.69
Xeris Pharmaceuticals (XERS) United States $0.124B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.122B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.114B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.102B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Biomerica (BMRA) United States $0.101B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
CTI BioPharma (CTIC) United States $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.084B 0.00
Addex Therapeutics (ADXN) Switzerland $0.079B 0.00
ElectroCore (ECOR) United States $0.076B 0.00
Recro Pharma (REPH) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
GTx (ONCT) United States $0.060B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
PolarityTE (PTE) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.049B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
IsoRay (ISR) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.042B 9.36
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 21.36
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00